Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists

Sharma, Pratima; Saini, Sameer; Kuhn, Latoya; Rubenstein, Joel; Pardi, Darrell; Marrero, Jorge; Schoenfeld, Philip; Saini, Sameer D; Kuhn, Latoya B; Rubenstein, Joel H; Pardi, Darrell S; Marrero, Jorge A; Schoenfeld, Philip S
February 2011
Digestive Diseases & Sciences;Feb2011, Vol. 56 Issue 2, p569
Academic Journal
journal article
Background: Screening of high-risk patients for hepatocellular carcinoma (HCC) may result in early diagnosis and improved outcomes. Our aim was to assess gastroenterologists' knowledge of HCC management guidelines established by the American Association for the Study of Liver Diseases (AASLD) and usual clinical practice.Methods: We surveyed gastroenterologists attending two gastroenterology board review courses regarding their knowledge of HCC screening guidelines and usual practice of screening for HCC. Practices were compared and adherence to the 2005 published HCC guidelines was assessed.Results: The median age of gastroenterology attending physicians (n = 160) was 41 years, and 75% were men with a median of 11.5 years of practice. A total of 79% of respondents correctly identified the high-risk patients who qualify for HCC screening. Most gastroenterologists correctly identified the screening methods (88.5%) and screening interval (98%). Among those who knew guideline recommendations (i.e., correct identification and certainty of guideline recommendations), 100% reported that they followed the guideline recommendation in their own practices. Regarding the management of abnormal test, 31% of gastroenterologists did not identify that referral for liver transplantation is the recommended management strategy for small HCC in a Child B patient with cirrhosis. The number of years in clinical practice (p = 0.30) and involvement in a malpractice suit (p = 0.34) did not affect the practice patterns.Conclusions: Most gastroenterologists correctly identified the common high-risk scenarios, methods, and interval of HCC screening as recommended by AASLD. Gastroenterologists who knew the HCC guidelines applied them in their own practice. However, approximately one-quarter do not know the appropriate management of a positive result, thereby likely hampering the overall effectiveness of screening.


Related Articles

  • Diagnóstico y tamizaje. Suárez Quintero, Yanette; Varón Puerta, Adriana // Revista Colombiana de Gastroenterología; 

    The great efforts of recent years to establish monitoring and diagnostic criteria have become increasingly effective in defining hepatocellular carcinoma (HCC) as a clinical entity. These efforts are amply justified by the increased frequency of diagnosis. Establishment of early diagnosis...

  • Gastroenterology and Hepatology: An Evolving Marriage, Not an Imminent Divorce. Friedman, Scott L.; McCullough, Arthur; Gores, Gregory // American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p10 

    The article presents the author's comments on gastroenterology and hepatology. The author says that hepatology is becoming complex and nuanced, and therefore represents a continued challenge for gastroenterologists in clinical practice to maintain expertise. It is stated that the American Board...

  • Hepatocellular Carcinoma Surveillance: A National Survey of Current Practices in the USA. Joshi, Kartik; Mendler, Michel; Gish, Robert; Loomba, Rohit; Kuo, Alexander; Patton, Heather; Kono, Yuko // Digestive Diseases & Sciences;Dec2014, Vol. 59 Issue 12, p3073 

    Background: The incidence rate of hepatocellular carcinoma (HCC) in the USA is rapidly rising. Surveillance using biannual ultrasound (US) is recommended, but actual practices are unknown. Aim: To determine current HCC surveillance practices among gastroenterology and hepatology providers in the...

  • Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma. Wild, Aaron T.; Gandhi, Nishant; Chettiar, Sivarajan T.; Aziz, Khaled; Gajula, Rajendra P.; Williams, Russell D.; Kumar, Rachit; Taparra, Kekoa; Zeng, Jing; Cades, Jessica A.; Velarde, Esteban; Menon, Siddharth; Geschwind, Jean F.; Cosgrove, David; Pawlik, Timothy M.; Maitra, Anirban; Wong, John; Hales, Russell K.; Torbenson, Michael S.; Herman, Joseph M. // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Sorafenib (SOR) is the only systemic agent known to improve survival for hepatocellular carcinoma (HCC). However, SOR prolongs survival by less than 3 months and does not alter symptomatic progression. To improve outcomes, several phase I-II trials are currently examining SOR with radiation (RT)...

  • The Knowledge of Colorectal Cancer Symptoms and Risk Factors among 10,078 Screening Participants: Are High Risk Individuals More Knowledgeable? Wong, Martin C. S.; Hirai, Hoyee W.; Luk, Arthur K. C.; Lam, Thomas Y. T.; Ching, Jessica Y. L.; Griffiths, Sian M.; Chan, Francis K. L.; Sung, Joseph J. Y. // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Objectives: We tested the a priori hypothesis that self-perceived and real presences of risks for colorectal cancer (CRC) are associated with better knowledge of the symptoms and risk factors for CRC, respectively. Methods: One territory-wide invitation for free CRC screening between 2008...

  • APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Cher Heng Tan; Su-Chong Albert Low; Choon Hua Thng // International Journal of Hepatology;2011, p1 

    Consensus guidelines for radiological diagnosis of hepatocellular carcinoma (HCC) have been drafted by several large international working groups. This article reviews the similarities and differences between the most recent guidelines proposed by the American Association for Study of Liver...

  • Shivakumar Vignesh Appointed SUNY Chief Of Gastroenterology.  // India -- West;10/3/2014, Vol. 39 Issue 46, pA32 

    No abstract available.

  • Closing Remarks. Kudo, Masatoshi // Clinical Drug Investigation;2012 Supplement 2, Vol. 32, p52 

    No abstract available.

  • Effects of 28Si Ions, 56Fe Ions, and Protons on the Induction of Murine Acute Myeloid Leukemia and Hepatocellular Carcinoma. Weil, Michael M.; Ray, F. Andrew; Genik, Paula C.; Yu, Yongjia; McCarthy, Maureen; Fallgren, Christina M.; Ullrich, Robert L. // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Estimates of cancer risks posed to space-flight crews by exposure to high atomic number, high-energy (HZE) ions are subject to considerable uncertainty because epidemiological data do not exist for human populations exposed to similar radiation qualities. We assessed the carcinogenic effects of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics